Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Clinical & Experimental Metastasis
Published in: Clinical & Experimental Metastasis 4/2005

01-06-2005

A New Model for Lymphatic Metastasis: Development of a Variant of the MDA-MB-468 Human Breast Cancer Cell Line that Aggressively Metastasizes to Lymph Nodes

Authors: Sharon A. Vantyghem, Alison L. Allan, Carl O. Postenka, Waleed Al-Katib, Michael Keeney, Alan B. Tuck, Ann F. Chambers

Published in: Clinical & Experimental Metastasis | Issue 4/2005

Login to get access
Metadata
Title
A New Model for Lymphatic Metastasis: Development of a Variant of the MDA-MB-468 Human Breast Cancer Cell Line that Aggressively Metastasizes to Lymph Nodes
Authors
Sharon A. Vantyghem
Alison L. Allan
Carl O. Postenka
Waleed Al-Katib
Michael Keeney
Alan B. Tuck
Ann F. Chambers
Publication date
01-06-2005
Publisher
Kluwer Academic Publishers
Published in
Clinical & Experimental Metastasis / Issue 4/2005
Print ISSN: 0262-0898
Electronic ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-005-0745-1

Other articles of this Issue 4/2005

Clinical & Experimental Metastasis 4/2005 Go to the issue

OriginalPaper

Invasion-associated MMP-2 and MMP-9 are Up-regulated Intracellularly in Concert with Apoptosis Linked to Melanoma Cell Detachment

OriginalPaper

Evaluation of the Interaction Between TGF β and Nitric Oxide in the Mechanisms of Progression of Colon Carcinoma

OriginalPaper

Inhibitors of Polyamine Biosynthesis Decrease the Expression of the Metalloproteases Meprin α and MMP-7 in Hormone-independent Human Breast Cancer Cells

OriginalPaper

An Orthotopic Model of Human Osteosarcoma Growth and Spontaneous Pulmonary Metastasis

OriginalPaper

Anti-apoptotic Proteins Induce Non-random Genetic Alterations that Result in Selecting Breast Cancer Metastatic Cells

OriginalPaper

Cathepsin D-related Disease-free Interval in pT1 Primary Breast Carcinomas: A Pilot Study
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits